Thailand Healthcare and Pharmaceuticals Sector Report 2016/2017

  • ID: 4313185
  • Report
  • Region: Thailand
  • 59 pages
  • EMIS, A Euromoney Institutional Investor Company
1 of 5
Thailand Is The Second-Largest Pharmaceutical Market In South East Asia, With Sales Of Thb 152.9Bn In 2015.

FEATURED COMPANIES

  • Bangkok Chain Hospital
  • Bumrungrad Hospital
  • Chularat Hospital Group
  • Mega Lifesciences
  • MORE
This report provides a complete and detailed analysis of the healthcare and pharmaceutical sector for Thailand. We present in-depth business intelligence in a standard format across countries and regions, providing a balanced mix between analysis and data.

What this report allows you to do:

Understand the key elements at play in the healthcare and pharmaceutical sector in Thailand
Access forecasts for growth in the sector
View key data on healthcare spending and health insurance in Thailand
Crystallise the forces both driving and restraining this sector in Thailand
Build a complete perspective on sector trade, investment and employment
Understand the competitive landscape and who the major players are
View M&A activity and major deals
Gain an understanding of the regulatory environment for the sector in Thailand
Build a clear picture of trends and issues for sub-sectors (medical institutions, pharmaceuticals manufacturing and distribution channels).
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Bangkok Chain Hospital
  • Bumrungrad Hospital
  • Chularat Hospital Group
  • Mega Lifesciences
  • MORE
01 EXECUTIVE SUMMARY
Sector in Numbers 2015
Sector Overview
Sector Snapshot
Sector Outlook
Driving Forces
Restraining Forces
02 SECTOR IN FOCUS
Thailand’s Healthcare System
Main Economic Indicators
Main Sector Indicators
Major Causes of Death in Thailand, 2014
Production
Sales and Prices
Expenditure
Global Positioning
Population Ageing in Southeast Asia
External Trade Pharmaceuticals
External Trade Health Services
Investment
03 COMPETITIVE LANDSCAPE
Highlights
Top Listed Companies
Stock Market
Top M&A Deals
M&A Activity
04 COMPANIES IN FOCUS
Bangkok Chain Hospital
Bangkok Dusit Medical Services
Bumrungrad Hospital
Chularat Hospital Group
Mega Lifesciences
05 REGULATORY ENVIRONMENT
Government Policy
Health Schemes Funding and Coverage
Government Policy - Prices
Investment Support
06 PHARMACEUTICALS
Highlights
Prescription Drugs
OTC Market
07 HEALTH SERVICES
Highlights
Focus Point – Thailand’s Population, 2015
Private Hospitals
Health Tourism
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Bangkok Chain Hospital
  • Bumrungrad Hospital
  • Chularat Hospital Group
  • Mega Lifesciences
  • MORE
Thailand is the second-largest pharmaceutical market in South East Asia, with sales of THB 152.9bn in 2015. The pharmaceutical industry specialises in generic drug production and this is the largest segment on the market. Spending on health is significant – 6.5% of GDP in 2014 – and the share of private health spending in it is only 14%. The country is a popular health tourism destination, offering high-quality services at relatively low prices.
Note: Product cover images may vary from those shown
5 of 5
Bangkok Chain Hospital
Bangkok Dusit Medical Services
Bumrungrad Hospital
Chularat Hospital Group
Mega Lifesciences
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll